Our results on gut microbial shift studies of APG‐157 + anti‐CTLA‐4 antibody treatment indicated that there is enhanced anti‐tumor immune response of the SCCVII H&N cancer cells possibly partly due to Lactobacillus. This evidence concerns the gene CTLA4 and cancer.